Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Compugroup Medical SE    COP   DE0005437305

Mes dernières consult.
Most popular
Analysis summary4-Traders Strategies

Benefit from the uptrend

share with twitter share with LinkedIn share with facebook
share via e-mail
02/06/2013 | 11:01am

CompuGroup Medical continues its bullish trend in order to test new highest level.

The company’s fundamentals are still strong. Sales are up 13.9% for one year. Analysts from Thomson Reuters consensus have revised largely upward their EPS estimates.

From a technical point of view, the share price is trading in a bullish trend on both short and on long term time scales. However, the buyer consensus seems to need to blow a little and a return on 20-day moving average is not excluded.

A decrease to the EUR 15.5 area allow a remobilization of a bullish consensus and then targeting a return to EUR 17 before revealing new targets upward in case of exceeding this level. The stop loss is set below EUR 15.2 short-term support.

© Zonebourse.com 2013
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (€)
Sales 2017 584 M
EBIT 2017 89,3 M
Net income 2017 47,5 M
Debt 2017 339 M
Yield 2017 0,83%
P/E ratio 2017 48,41
P/E ratio 2018 23,27
EV / Sales 2017 4,57x
EV / Sales 2018 3,56x
Capitalization 2 328 M
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Compugroup Medical SE Technical Analysis Chart | COP | DE0005437305 | 4-Traders
Duration : Period : Week
Compugroup Medical SE Technical Analysis Chart | COP | DE0005437305 | 4-Traders